单细胞RNA测序技术在肺癌肿瘤微环境研究中的进展

免疫微环境对肿瘤的发生发展起着关键作用。近年来，随着高通量测序技术的飞速发展，研究人员对肿瘤微环境中的免疫细胞组成及其功能有了更深入的了解。然而，传统的群体测序技术难以解析单个细胞层面的异质性，限制了对肿瘤微环境复杂性的全面理解。单细胞RNA测序技术的兴起，为揭示肺癌免疫微环境的异质性带来了新的机遇。当前以T细胞为中心的免疫治疗在临床中容易出现免疫原性耐药或者免疫相关性肺炎等影响预后的副作用，其关键因素是肿瘤微环境中免疫细胞与肿瘤细胞的相互作用发生了变化。而单细胞RNA测序技术可以从细胞间互作、拟时序分析等角度揭示肿瘤微环境中不同亚群间的起源与作用，进而发现新的细胞亚群或新生生物标志物，为揭示免疫治疗的耐药及疗效监测等提供新的途径。该综述系统回顾了单细胞RNA测序技术在揭示肺癌特别是免疫治疗后肺癌微环境异质性方面的最新研究进展，为促进肺癌免疫治疗的精准化与个体化提供参考。


Sun et al. [56]
VITApilote® snRandom-seq, IMC LUAD B cell, plasma cell, T cell An extensive single-cell analysis revealed distinctive immune niches in different organ-specific environments.Notably, primary LUAD and adrenal gland metastases exhibited a significant presence of B cells, plasma cells, and various T cell subtypes (including activated, exhausted, and memory T cells), suggesting a robust immune environment conducive to immunotherapy effectiveness.Conversely, immunosuppressive environments characterized by the presence of collagen I and high expression of the T cell exhaustion marker TIM-3 were identified in brain and liver metastases, indicating a potential challenge for immunotherapy in these sites.

Sorin et al. [57]
10x Genomics ®scRNA-seq, IMC NSCLC Tumor cell, T cell, monocyte The study found that CXCL13 expression is associated with the efficacy of ICIs.Recombinant CXCL13 can enhance the in vivo response to anti-PD-1 therapy, possibly due to the increase in antigen-stimulated T cell subgroups and the reduction in CCR2 + monocytes.

Leader et al. [58]
10x Genomics ®scRNA-seq, CITE-seq, TCR-seq NSCLC Tumor cell, T cell, Plasma cell, Mac The study developed a detailed immunological profile of early-stage lung cancer and introduced the LCAM module consisting of PDCD1 + CXCL13 + activated T cells, IgG + plasma cells, and SPP1 + macrophages, which serves as a direct indicator of antigen-specific anti-tumor immune activation.This framework assists in understanding and enhancing immunotherapeutic strategies.

Zhu et al. [59]
10x Genomics ®scRNA-seq, ST LUAD Tumor cell, Treg cell The study identified a UBE2C + subpopulation in LUAD crucial for tumor invasiveness.In the LUAD TME, NK cells and MALT + B cells increased significantly in early stages, whereas Treg cells and secretory B cells decreased as LUAD progressed to advanced stages.These findings support the development of personalized treatment strategies for aggressive LUAD.
Sinjab et al. [60]   10x Genomics ®scRNA-seq, ST LUAD Tumor cell, Dendritic cell, Mac This study identified distinct immune checkpoint receptor and cytokine receptor interactions within different regions of LUAD.Decreased overlap of L-R interactions was observed in distant tumor regions compared to proximal areas.Additionally, increased interactions involving immune checkpoint proteins CD24 with LGALS9 in tumor epithelial cells, and SIGLEC10 in dendritic and macrophage cells, as well as HAVCR2, suggest that regional differences in these interactions could affect the tumor's immune microenvironment and impact the effectiveness of immunotherapy.

environment 【Copyright statement】Copyright © 2024 ,
Chinese Journal of Lung Cancer.This paper was supported by the grants from Shanghai Health Leadership Talent (No.2022LJ014); Frontiers of Biomedical Research Base of Inflammation-Cancer Transformation Diseases in Shanghai (No.2021 Science and Technology 03-12) and National Natural Science Foundation of China (No.82174245)(All to Jianhui TIAN).